scholarly journals Evaluation of Collagen Neoepitope Biomarkers in a Phase 2 Trial of BMS-986020, A Lysophosphatidic Acid Receptor Antagonist, for the Treatment of Idiopathic Pulmonary Fibrosis

2020 ◽  
Author(s):  
Y. Luo ◽  
B. Decato ◽  
S.M. Palmer ◽  
S. Du ◽  
E.D. Charles ◽  
...  
Keyword(s):  
Idiopathic Pulmonary Fibrosis ◽  
Pulmonary Fibrosis ◽  
Receptor Antagonist ◽  
Lysophosphatidic Acid ◽  
Phase 2 ◽  
Acid Receptor ◽  
Lysophosphatidic Acid Receptor ◽  
Phase 2 Trial

The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak

2007 ◽  
Vol 14 (1) ◽  
pp. 45-54 ◽  
Author(s):  
Andrew M Tager ◽  
Peter LaCamera ◽  
Barry S Shea ◽  
Gabriele S Campanella ◽  
Moisés Selman ◽  
...  
Keyword(s):  
Pulmonary Fibrosis ◽  
Lung Injury ◽  
Lysophosphatidic Acid ◽  
Vascular Leak ◽  
Acid Receptor ◽  
Lysophosphatidic Acid Receptor

scholarly journals MP09-01 EFFECT OF ASP6432, A TYPE 1 LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONIST, ON URETHRAL FUNCTION DURING THE VOIDING PHASE IN RATS

2018 ◽  
Vol 199 (4S) ◽  
Author(s):  
Kazuyuki Sakamoto ◽  
Yukiko Noguchi ◽  
Katsunori Imazumi ◽  
Koji Ueshima ◽  
Akiyoshi Ohtake ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Lysophosphatidic Acid ◽  
Acid Receptor ◽  
Lysophosphatidic Acid Receptor ◽  
Urethral Function

scholarly journals Orally active lysophosphatidic acid receptor antagonist attenuates pancreatic cancer invasion and metastasis in vivo

2012 ◽  
Vol 103 (6) ◽  
pp. 1099-1104 ◽  
Author(s):  
Mayumi Komachi ◽  
Koichi Sato ◽  
Masayuki Tobo ◽  
Chihiro Mogi ◽  
Takayuki Yamada ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Receptor Antagonist ◽  
Lysophosphatidic Acid ◽  
Cancer Invasion ◽  
Invasion And Metastasis ◽  
Acid Receptor ◽  
Lysophosphatidic Acid Receptor ◽  
Orally Active
Sign in / Sign up

Export Citation Format

Share Document